Obesity and tobacco abuse, widely recognised as serious health hazards, are increasing in prevalence. Obesity is associated with numerous metabolic complications such as dyslipidemia, type 2 diabetes and cardiovascular diseases. Smoking is a high risk factor for hypertension, lung carcinoma …

How much weight can I lose by taking Acomplia?

Exhaustive clinical trials conducted with Acomplia on more than 6800 patients yielded substantial results. Patients given Acomplia for a period …

NEW YORK - An HSBC analyst upgraded Sanofi-Aventis SA Wednesday,Rimonabant brand citing the French drug maker’s full pipeline and shrugging off its failure to receive U.S. approval for the weight-loss drug Acomplia.In late June, Sanofi-Aventis (nyse: SNY - news - …